Luiz Pedro Carvalho, PhD
luizcarvalholab.bsky.social
Luiz Pedro Carvalho, PhD
@luizcarvalholab.bsky.social
Professor of Chemistry @UFScripps
Interested in enzymology, bacterial metabolism, chem bio, mycobacteria, antibiotic discovery and antibiotic resistance. Former group leader at NIMR and The Crick.
Out now in @elife.bsky.social elifesciences.org/reviewed-pre...

Agnese Serafini @agnese75.bsky.social back in Italy discovered that Mtb splits its Krebs cycle during extreme iron starvation. An unprecedented mechanism to work around nutritional immunity and persist. More cool stuff in there too...
Mycobacterium tuberculosis partitions the Krebs cycle to persist under iron starvation
elifesciences.org
August 7, 2025 at 4:57 PM
Reposted by Luiz Pedro Carvalho, PhD
My "Crash Course in …Immunology" is now posted on YouTube youtu.be/nBC9vvlTxF8. Taken from a public lecture @crick.ac.uk on history and basic concepts in immunity. Aimed at the lay public and those seeking an introductory overview.
The Past, Present and Future of Immunology Research – with Caetano Reis e Sousa
YouTube video by Francis Crick Institute
youtu.be
August 4, 2025 at 8:11 PM
Reposted by Luiz Pedro Carvalho, PhD
🚨New pre-print 🚨
We introduce our new tool GOLD-GWAS and demonstrate its use by digging into the evolution of MRSA facilitated by SCCmec

This work was led by talented PhD student @seungwonko.bsky.social who did most of the computational heavylifting 1/n

www.biorxiv.org/content/10.1...
Genome co-adaptation and the evolution of methicillin resistant Staphylococcus aureus (MRSA)
Background: Antimicrobial resistance (AMR) in bacterial pathogens is a major threat to global health, rendering standard treatments ineffective and increasing the risk of severe infection or death. Re...
www.biorxiv.org
July 23, 2025 at 10:50 AM
Reposted by Luiz Pedro Carvalho, PhD
Reposted by Luiz Pedro Carvalho, PhD
Happy to present a new flavin-binding protein that unexpectedly displays a large Stokes shift due to excited state proton transfer. Not submitted yet - feedback is welcome!

doi.org/10.1101/2025...
June 17, 2025 at 9:12 AM
Reposted by Luiz Pedro Carvalho, PhD
Allelic variations and gene cluster modularity act as nonlinear bottlenecks for #cholera emergence www.pnas.org/doi/10.1073/...
Allelic variations and gene cluster modularity act as nonlinear bottlenecks for cholera emergence | PNAS
The underlying factors that lead to specific strains within a species to emerge as human pathogens remain mostly enigmatic. The diarrheal disease c...
www.pnas.org
May 29, 2025 at 10:19 AM
Reposted by Luiz Pedro Carvalho, PhD
Delighted to share our newest pre-print. Here, we describe a very short synthesis (11 steps, LLS) of the polyether antibiotic lasalocid acid A.
doi.org/10.26434/che...
May 29, 2025 at 11:44 AM
Reposted by Luiz Pedro Carvalho, PhD
🚨 Out now!

A new study showing a third track for coordination of septal peptidoglycan synthesis and degradation by FtsN in E. coli

#MicroSky 🦠🧪

www.nature.com/articles/s41...
Third track model for coordination of septal peptidoglycan synthesis and degradation by FtsN in Escherichia coli - Nature Microbiology
Partitioning of FtsN and the septal peptidoglycan synthesis complex between an active synthesis track and an inactive denuded glycan track coordinates opposing peptidoglycan synthesis and degradation ...
www.nature.com
May 28, 2025 at 3:44 PM
Reposted by Luiz Pedro Carvalho, PhD
Francesca Ciccarelli @ciccarellilab.bsky.social is up next to tell us about spatial drivers of response to immunotherapy in colon cancer

Thank you to TransnetYX for sponsoring Francesca’s talk!

@qmbci.bsky.social | @crick.ac.uk | @cruk-cityoflondon.bsky.social | #BICC2025
May 28, 2025 at 11:18 AM
Reposted by Luiz Pedro Carvalho, PhD
🚨Job Alert!🚨

@natmetabolism.nature.com‬ seeks an Associate or Senior #Editor to join our team. If being a #Metabolism Editor is for you, and you are based in, or open to moving to New York or Shanghai, check out our #job posting below and apply before June 11th!
Associate or Senior Editor Nature Metabolism
Job Title: Associate or Senior Editor Nature Metabolism Location: New York or Shanghai Application Deadline: June 10th, 2025 About Springer Nature Group Springer Nature opens the doors to discovery for researchers, educators, clinicians and other professionals. Every day, around the globe, our imprints, books, journals, platforms and technology solutions reach millions of people. For over 180 years our brands and imprints have been a trusted source of knowledge to these communities and today, more than ever, we see it as our responsibility to ensure that fundamental knowledge can be found, verified, understood and used by our communities – enabling them to improve outcomes, make progress, and benefit the generations that follow. Visit http://group.springernature.com/ and follow @SpringerNature / @SpringerNatureGroup. About the Brand Nature Portfolio is a flagship portfolio of journals, products and services including Nature and the Nature-branded journals, dedicated to serving the scientific community. Visit nature.com and follow @Nature / @NaturePortfolio. About the Role Nature Metabolism seeks an Associate or Senior Editor to join our expanding editorial team. Do you love science but feel that a research career isn’t enough to sate your desire to learn more about the natural world? Do you enjoy reading papers outside your chosen area of research? If the answer is ‘yes’ to any or both questions, you could be the person we’re looking for to join the editorial team of Nature Metabolism. This role can be in our New York or Shanghai offices on a hybrid working model. Role Responsibilities: Working closely with other editors on all aspects of the editorial process, including manuscript selection and overseeing peer review. Commissioning and editing News & Views and Reviews articles and writing for the journal. Organizing and attending conferences and visiting laboratories. Maintaining close contact with the international scientific community. The role requires broad scientific interest and strong interpersonal, communication, and organizational skills. Fluency in spoken and written English, along with a willingness to learn and engage with the scientific community, is essential. Experience, Skills & Qualifications: A Ph.D. in a relevant research field is required. Postdoctoral research experience is preferred but not essential A broad interest in science and the ability to critically evaluate research submitted to the journal Applications from all scientific areas covered by the journal are welcome but candidates with expertise in cellular metabolic biology (e.g. mitochondrial biology), metabolic biochemistry or metabolic tracing are especially encouraged. Experience in cancer research or immunology is a plus. Excellent interpersonal, communication and organizational skills Fluent in spoken and written English To Apply: Please submit a cover letter explaining your interest in the position and your salary expectations please submit a CV concise (up to 500 words) discussion of recent developments or trends in the wider metabolism field, which you have found particularly exciting (and explaining why). Springer Nature US provides a comprehensive and competitive benefits package which includes the benefit offerings listed below: • Medical, Dental and Vision • 401(k) with company match and contribution • Hybrid office working policy, Summer Hours, and paid time off • Flexible Spending and Commuter programs • Multiple Life insurance options • Disability coverage • Tuition Assistance • Voluntary benefits: Identity Theft Protection, Pet Insurance, and Legal Assistance Insurance • Employee Assistance Program • Family friendly benefits and a variety of employee discounts • An array of Employee Social Networks US Annualized Base Salary Range: Associate Editor: $80,000 | Senior Editor: $95,000. The salary offer may vary based on work experience, education, skill level and equity. The US salary range does not align with the salary ranges in other countries when converted to the currency of that country. Springer Nature is an Equal Opportunity Employer that complies with the laws and regulations set forth in the following https://www.eeoc.gov/sites/default/files/2023-06/22-088_EEOC_KnowYourRights6.12ScreenRdr.pdf At Springer Nature, we value the diversity of our teams and work to build an inclusive culture, where people are treated fairly and can bring their differences to work and thrive. We empower our colleagues and value their diverse perspectives as we strive to attract, nurture and develop the very best talent. Springer Nature was awarded Diversity Team of the Year at the 2022 British Diversity Awards. Find out more about our DEI work here: https://group.springernature.com/gp/group/taking-responsibility/diversity-equity-inclusion If you have any access needs related to disability, neurodivergence or a chronic condition, please contact us so we can make all necessary accommodation. For more information about career opportunities in Springer Nature please visit https://careers.springernature.com/ #LI-DT1 Job Posting End Date: 11-06-2025 We are an ambitious and dynamic organisation, and home to some of the best-known names in research, educational and professional publishing. Working at the heart of a changing industry, we are always looking for great people who care about delivering quality to our customers and the communities we work alongside. In return, you will find that we open the doors to discovery for all our employees – offering opportunities to learn from some of the best in the business, with a culture that encourages curiosity and empowers people to find solutions and act on their instincts. Whether you are at the beginning of your career or are an experienced professional, we invite you to find out more about the roles we offer and explore our current vacancies. We are a global and progressive business, founded on a heritage of trusted and respected brands – including Springer, founded in 1842, Macmillan, founded in 1843 and Nature, first published in 1869. Nearly two centuries of progress and advancement in science and education have helped shape the business we are today. Research and learning continues to be the cornerstone of progress, and we will continue to open doors to discovery through trusted brands and innovative products and services. Springer Nature Group was created in May 2015 through the combination of Nature Publishing Group, Macmillan Education and Springer Science+Business Media.
bit.ly
May 22, 2025 at 4:25 PM
Reposted by Luiz Pedro Carvalho, PhD
Excited to share the first beta release of AMRrules at #ABPHM! (Poster 42 tonight)
interpretamr.github.io/AMRrules
May 22, 2025 at 9:35 AM
Reposted by Luiz Pedro Carvalho, PhD
🔥 𝐒𝐚𝐯𝐞 𝐭𝐡𝐞 𝐃𝐚𝐭𝐞: 𝟖𝐭𝐡 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟓 🔥
NDI³ & NordInfect join forces in organizing the 2025 Northern Germany Meeting on Infection, Immunology & Inflammation at @fzborstel.bsky.social
𝐊𝐞𝐲𝐧𝐨𝐭𝐞 𝐬𝐩𝐞𝐚𝐤𝐞𝐫𝐬:
✨Olivier Neyrolles (France)
✨Max Gutierrez (UK)
✨Susanne Häußler (Germany)
▶️ ndi3.fz-borstel.de
May 22, 2025 at 10:06 AM
Reposted by Luiz Pedro Carvalho, PhD
🧵5 Top Free Alternatives to BioRender for Scientific Illustrations!

These five websites offer free scientific illustrations for biologists. Great for presentations, research papers and other research communication needs.

Save and share the post!
May 13, 2025 at 7:55 PM
Reposted by Luiz Pedro Carvalho, PhD
Proud to share the results of a study that tells us how M. tuberculosis remodels central metabolism in response to iron deficiency.
@agnese75.bsky.social @luizcarvalholab.bsky.social
www.biorxiv.org/content/10.1...
Mycobacterium tuberculosis partitions the Krebs cycle to persist under iron starvation
In this study, we investigated how iron limitation alters central metabolism in Mycobacterium tuberculosis using metabolomics and stable isotope tracing. Our findings reveal a well-orchestrated metabo...
www.biorxiv.org
May 13, 2025 at 12:01 PM
Reposted by Luiz Pedro Carvalho, PhD
Out in Nature today: A new immune signaling molecule, His-ADPR, is produced by defensive TIR domain proteins in bacteria to protect from phage

Joint work with the Tamulaitienė and Kranzusch labs

www.nature.com/articles/s41...

Congrats Carmel Avraham, Dziugas Sabonis, Renee Chang and co-authors!
April 30, 2025 at 6:44 PM
Reposted by Luiz Pedro Carvalho, PhD
Fungi can protect the environment, grow food and even develop new medicines. 🍄

But they can also cause disease.

As climate change spreads pathogenic fungi to new places, more people worldwide will be at risk.

Learn more in our explainer ⤵️
wellcome.org/news/will-cl...
Will climate change lead to more fungal infections? | News | Wellcome
Fungi can keep us healthy or cause disease. As climate change drives fungi to adapt, learn how we can harness the benefits and tackle the threats.
wellcome.org
April 24, 2025 at 1:10 PM
Reposted by Luiz Pedro Carvalho, PhD
Identification of a specific, pre-existing beta-lactam antibiotic for treating Lyme disease Borrelia infections. Cool new report from @jutraslab.bsky.social Brandon Jutras & colleagues.
pubmed.ncbi.nlm.nih.gov/40267215/

#MicroSky 🦠🧫🔬
April 24, 2025 at 12:12 PM
Reposted by Luiz Pedro Carvalho, PhD
😮
The unique #CellEnvelope of #corynebacteria: @tbharat-lab.bsky.social &co map the C. glutamicum cell surface, revealing a patchy S-layer & specific assembly of the PS2 protein, thereby informing our understanding of cell envelopes that contain #MycolicAcids @plosbiology.org 🧪 plos.io/3Y6JNgw
April 23, 2025 at 8:50 PM
Arriving in California for @heran.bsky.social GRC on the biology of Mycobacteria! 🤩😍 see you all very soon!
April 7, 2025 at 12:45 AM
Reposted by Luiz Pedro Carvalho, PhD
Excited to share our latest, out today in @naturemicrobiol.bsky.social Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium www.nature.com/articles/s41... @idpittstop.bsky.social
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium - Nature Microbiology
Genomic and functional analyses of healthcare-associated vancomycin-resistant Enterococcus faecium reveal that bacteriocin T8 is enriched in emergent lineages and provides a competitive advantage in v...
www.nature.com
March 21, 2025 at 1:46 PM
Reposted by Luiz Pedro Carvalho, PhD
Phylogeny-guided natural product discovery reveals new chemical space and a new antifungal effective against drug-resistant strains

🧪

www.nature.com/articles/s41...
A polyene macrolide targeting phospholipids in the fungal cell membrane - Nature
Mandimycin, a polyene macrolide, exhibits strong antifungal activity and possesses a mode of action that is distinct from other compounds of this class.
www.nature.com
March 20, 2025 at 8:38 AM